Literature DB >> 3410938

Glycosylated and nonglycosylated prolactin in serum during pregnancy.

E Markoff1, D W Lee, D R Hollingsworth.   

Abstract

To study the pattern of release of glycosylated (G-PRL) and nonglycosylated (PRL) under various physiological conditions, we studied normal women from the first trimester of pregnancy through the postpartum period. Immunoreactive PRL variants were immunoprecipitated from 100-microL aliquots of serum, and the precipitates were subjected to gel electrophoresis in the presence of sodium dodecyl sulfate, electrotransferred to nitrocellulose paper, immunoblotted with anti-PRL serum and [125I]protein-A, and autoradiographed. The relative concentrations of the two forms of PRL were indicated by the intensity of the electrophoretic bands. Before pregnancy, serum G-PRL was the predominant PRL form. As pregnancy progressed, increasing amounts of PRL, compared to G-PRL, appeared in the serum, and it reached a maximum by the third trimester. G-PRL was found at all stages of pregnancy, even when the amount of PRL was greatest. After parturition in nonnursing mothers the PRL band again decreased; however, in nursing mothers the PRL band remained prominent. We conclude that the G-PRL and PRL variants may fulfill different physiological roles and, under certain conditions, such as pregnancy and lactation, more of the nonglycosylated PRL may be produced to fill special requirements.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3410938     DOI: 10.1210/jcem-67-3-519

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Agalactosyl IgG in pristane-induced arthritis. Pregnancy affects the incidence and severity of arthritis and the glycosylation status of IgG.

Authors:  S J Thompson; Y Hitsumoto; Y W Zhang; G A Rook; C J Elson
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  Secretion of 23 kDa and glycosylated prolactin by rat pituitary cell culture in serum-free media: a comparative morphological, cyto- and immunochemical study.

Authors:  F Bollengier; M Espeel; A Matton; A Mahler; L Vanhaelst
Journal:  Endocrine       Date:  1995-01       Impact factor: 3.633

3.  Bioactivity and glycosylation of circulating prolactin in various physiological and pathological conditions.

Authors:  G M Gambino; P Beck-Peccoz; S Borgato; G Faglia; A Spada; L Persani
Journal:  Pituitary       Date:  1999-11       Impact factor: 4.107

4.  50 kD prolactin binding protein in schizophrenics on neuroleptic medication.

Authors:  A M Walker; C A Peabody; T W Ho; M D Warner
Journal:  J Psychiatry Neurosci       Date:  1992-06       Impact factor: 6.186

5.  Variations in the molecular forms of prolactin during the menstrual cycle, pregnancy and lactation.

Authors:  M E Fonseca; R Ochoa; C Morán; A Zárate
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.